These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31145699)

  • 1. A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans.
    Charidemou E; Ashmore T; Li X; McNally BD; West JA; Liggi S; Harvey M; Orford E; Griffin JL
    JCI Insight; 2019 Jun; 4(12):. PubMed ID: 31145699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver.
    Hörbelt T; Knebel B; Fahlbusch P; Barbosa D; de Wiza DH; Van de Velde F; Van Nieuwenhove Y; Lapauw B; Thoresen GH; Al-Hasani H; Müller-Wieland D; Ouwens DM; Kotzka J
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2671-2684. PubMed ID: 31336149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals.
    Rabøl R; Petersen KF; Dufour S; Flannery C; Shulman GI
    Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13705-9. PubMed ID: 21808028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.
    Park H; Liu Y; Kim HS; Shin JH
    Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes.
    Liu Y; Lin H; Jiang L; Shang Q; Yin L; Lin JD; Wu WS; Rui L
    J Clin Invest; 2020 Jun; 130(6):2992-3004. PubMed ID: 32365055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet.
    Lutz SZ; Hennige AM; Peter A; Kovarova M; Totsikas C; Machann J; Kröber SM; Sperl B; Schleicher E; Schick F; Heni M; Ullrich A; Häring HU; Stefan N
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2041-2053. PubMed ID: 30541128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased hepatic de novo lipogenesis and mitochondrial efficiency in a model of obesity induced by diets rich in fructose.
    Crescenzo R; Bianco F; Falcone I; Coppola P; Liverini G; Iossa S
    Eur J Nutr; 2013 Mar; 52(2):537-45. PubMed ID: 22543624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver.
    Surugihalli C; Muralidaran V; Ryan CE; Patel K; Zhao D; Sunny NE
    Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E299-E313. PubMed ID: 36791321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance.
    Roumans KHM; Lindeboom L; Veeraiah P; Remie CME; Phielix E; Havekes B; Bruls YMH; Brouwers MCGJ; Ståhlman M; Alssema M; Peters HPF; de Mutsert R; Staels B; Taskinen MR; Borén J; Schrauwen P; Schrauwen-Hinderling VB
    Nat Commun; 2020 Apr; 11(1):1891. PubMed ID: 32312974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Softic S; Cohen DE; Kahn CR
    Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.
    Okuma C; Ohta T; Tadaki H; Ishigure T; Sakata S; Taniuchi H; Sano R; Hamada H; Kume S; Nishiu J; Kakutani M
    J Pharmacol Sci; 2015 Jul; 128(3):150-7. PubMed ID: 26215699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease.
    Ter Horst KW; Vatner DF; Zhang D; Cline GW; Ackermans MT; Nederveen AJ; Verheij J; Demirkiran A; van Wagensveld BA; Dallinga-Thie GM; Nieuwdorp M; Romijn JA; Shulman GI; Serlie MJ
    Diabetes Care; 2021 Feb; 44(2):489-498. PubMed ID: 33293347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
    Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
    Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ; Newton KP; Nyangau EM; Sirlin CB; Ugalde-Nicalo PA; Welsh JA; Hellerstein MK; Schwimmer JB; Vos MB
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.